Eli Lilly Korea wins commendation after signing $500 million bio innovation MOU
AI Summary- Eli Lilly Korea received a Korea Health Industry Development Institute Director’s Commendation for organizational contributions.
- Eli Lilly Korea signed a five-year, $500 million MOU with the Ministry of Health and Welfare.
- Lilly Gateway Labs Incheon is scheduled for completion in 2027 at Samsung Biologics’ Second Bio Campus.